Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study (Q43693973)

25 November 2017

Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study (English)

1 reference

25 November 2017

1 reference

1 reference

4

1 reference

25 November 2017

Oscar H Franco

6

0 references

Albert Hofman

5

object named as

Albert Hofman

1 reference

25 November 2017

Emmilia A Dowlatshahi

1

1 reference

25 November 2017

Maryam Kavousi

2

1 reference

25 November 2017

Tamar Nijsten

3

1 reference

25 November 2017

Marlies Wakkee

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

14 March 2013

1 reference

Journal of Investigative Dermatology

25 November 2017

1 reference

25 November 2017

133

1 reference

25 November 2017

2347-2354

1 reference

25 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2013.131

25 November 2017

0 references

cites work

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Coronary artery disease in patients with psoriasis referred for coronary angiography

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis patients show signs of insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Managing comorbid disease in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Subclinical atherosclerosis in patients with chronic psoriasis: a potential association

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Carotid intima-media thickness and serum leptin in psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

The risk of stroke in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Epidemiology of psoriatic arthritis in the population of the United States.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Chronic plaque psoriasis is associated with increased arterial stiffness.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

The Rotterdam Study: 2012 objectives and design update

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis: a possible risk factor for development of coronary artery calcification.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Peripheral arterial disease: identification and implications

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2013.131

1 reference

7 January 2021

Clinical severity of psoriasis in last 20 years of PUVA study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

[Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement]

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Coronary calcification improves cardiovascular risk prediction in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Medical comorbidity associated with psoriasis in adults: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2013.131

7 January 2021

Identifiers

DOI

10.1038/JID.2013.131

1 reference

25 November 2017

1 reference